LAVA Therapeutics NV (LVTX) — Cash Flow Reinvestment Rate
LAVA Therapeutics NV (LVTX) has a Cash Flow Reinvestment Rate of 0.12x as of December 2022, reinvesting $4.40 Million (capex $265.00K plus investments $-4.14 Million) from operating cash flow of $35.73 Million. See LAVA Therapeutics NV (LVTX) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
LAVA Therapeutics NV Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for LAVA Therapeutics NV across 1 annual periods. For the full cash flow conversion analysis, see LVTX cash flow conversion.
Annual Cash Flow Reinvestment Rate for LAVA Therapeutics NV (2022–2022)
Year-by-year capital reinvestment analysis for LAVA Therapeutics NV. See LVTX financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 2.46x | $9.93 Million | $4.04 Million | $587.00K | — |